AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
CNBC
Read Full Article at CNBC →Ad Slot — In-Article (728x90)
AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.
This is a summary. For the full story, read the original article at CNBC.
Original source: CNBC